Share your research with a global audience and contribute to advancing kidney care worldwide. Abstract presentations are the heart of the World Congress of Nephrology—previous editions have featured over 1,300 poster sessions on average. Be part of this vibrant exchange of knowledge and innovation.
Important dates
Submissions open
Submissions deadline
Notification of acceptance
Abstract categories and topics
Preserving Kidney Health: Exploring the mechanisms, progression, and management of acute and chronic kidney disease, dialysis, and transplantation
- Acute Kidney Injury Clinical, Drugs, AKI-CKD Continuum
- Acute Kidney Injury – Mechanisms, Experimental Models and Biomarkers
- Acid-base and Electrolyte Abnormalities in Kidney Disease
- Other AKI
- Chronic Kidney Disease Diagnosis, Classification and Progression
- Chronic Kidney Disease Complications
- Diabetic Kidney Disease, Drugs and Treatments
- Chronic Kidney Disease, Experimental Models, Biomarkers, Precision Medicine
- Inflammation, Fibrosis, Matrix Biology and Oxidative Stress
- Urologic Disorders – Stones, Nephrocalcinosis
- Other CKD
- Haemodialysis, Haemodiafiltration and Vascular Access
- Kidney Transplantation and Transplant Immunology
- Peritoneal Dialysis
Better Kidney Health: Addressing public health challenges, epidemiology, and innovative approaches to improve kidney care globally
- Tropical Kidney Diseases
- Epidemiology, Outcomes and Health Service Research Related to CKD or Its Complications
- Special Challenges in the Burden and Management of CKD in Developing Countries
- Bioethics, Supportive/Palliative Care and Quality of Life in Kidney Failure
- Other KF (Kidney Failure)
- Artificial Intelligence and Machine Learning
- Covid-19 and The Kidney
The Smart Kidney: Advancing research in glomerular diseases, genetics, and cutting-edge nephrology technologies
- Experimental Models – Glomerulonephritis
- Clinical Glomerulonephritis
- Physiology of Tubular Function and Tubulointerstitial Kidney Disease, Renal Model Systems (Organoids and Kidney on a Chip)
- Genetics and Epigenetics (Including Common and Rare Genetic Diseases)
- Nephrotic Syndrome
The Interconnected Kidney: Investigating the kidney’s role in systemic conditions, pregnancy, cancer, and vascular health
- Kidney in Pregnancy and Post-Partum
- Cancer Therapy And Kidney Disease
- Renal and Electrolyte Manifestation of Onconephrology
- Vascular Biology and Endothelial Function
- Essential Hypertension and Renovascular Kidney Disease
- Epidemiology, Outcomes and Health Services Research in Dialysis
Education: Enhancing nephrology training, curriculum development, and digital learning opportunities
- Training
- Social media
- Curriculum
- Online learning
Late-Breaking Clinical Trials: Showcasing groundbreaking research and newly emerging data shaping the future of kidney care
Note: A placeholder abstract must be submitted by October 22, 2025, to qualify for late-breaking submission.
(Read the specific conditions that apply to this category)
Abstract instructions and requirements
- Language: English
- Character limit: Up to 3,400 characters, including spaces. This excludes authors’ names, affiliations, keywords, and any tables or graphs inserted as images.
- Structure: Use a structured format with introduction, methods, results, and conclusion sections. Review carefully for typos, misspellings, and errors before submission.
- Co-authors: You may list up to 15 co-authors per abstract.
- Images:Images must be in JPEG or PNG format (maximum 640wx480h pixels, 1.5 MB).
- Case reports: Case reports that present novel hypotheses, pathologies, treatments, or ethical issues are welcome. However, they are only likely to be selected if the originality is highlighted effectively.
- Co-authors: You may list up to 15 co-authors per abstract.
- Encore abstracts: Allowed if permitted by both the initial and subsequent conferences. Authors must disclose this at the end of the abstract: “This abstract was also submitted for the [insert meeting title] congress.“
- Ethical compliance: Research must adhere to the Declaration of Istanbul on Organ Trafficking and Transplant Tourism.
- By submitting, you confirm that your work complies with ethical principles regarding live donation and research on human subjects.
- Generative AI disclosure: If AI-assisted tools were used in writing, consult the “Declaration of Generative AI and AI-Assisted Technologies” section and disclose accordingly during the submission process.
- Embargo policy: For abstracts accepted for presentation and publication during WCN’26, the following embargo policy applies.
Abstract submission conditions
- Accepted abstracts will be published online in Kidney International Reports®. No printed abstract book will be available.
- Presenting authors must register for the congress by January 14, 2026, to have their abstract published and to present a poster. Failure to register by this date will result in the abstract not being published or presented.
- Presenters must register using the same email used for abstract submission. If they fail to do so and do not communicate the change of email to the Abstract team, the abstract might not be published in Kidney International Reports® or presented onsite. WCN organizers will not be held responsible for non-publication.
- If the presenting author is unable to attend, a co-author may present the abstract instead, provided they are registered.
- The original presenter must inform the Abstract team ([email protected]) of the change by January 14, 2026 and provide the registration number of the new presenting author at the same time. Failure to do so will result in abstract withdrawal. No exceptions.
- Abstract handling fee is 50 USD per abstract, non-refundable.
- Fee waivers apply to submitters from low-income countries (as per World Bank income classifications)
- Payment must be made via credit card (American Express, MasterCard, or Visa). Bank transfers are not accepted.
- Once submitted, abstracts cannot be edited or withdrawn.
- All copyrights are assigned to the International Society of Nephrology (ISN).
- All submitted abstracts will be considered for poster presentations.
Late-breaking clinical trials abstracts showcase groundbreaking data and significant advancements that would not have been available for the regular abstract deadline. The Scientific Program Working Group will review these abstracts for potential presentation at WCN’26.
Key considerations
- These abstracts highlight novel, practice-changing studies, including the latest trial data and research findings.
- This is not an extension of the general submission deadline.
- A placeholder abstract must be submitted during the regular submission period (deadline: October 22, 2025).
Conditions
- Accepted abstracts will be published online in Kidney International Reports® upon author confirmation. No printed abstract book will be available.
- Selected abstracts may be invited for oral presentation at WCN’26.
- Presenting authors must register for the congress by January 14, 2026, to have their abstract published and to present a poster. Failure to register by this date will result in the abstract not being published or presented.
- Presenters must register using the same email used for abstract submission. If they fail to do so and do not communicate the change of email to the Abstract team, the abstract might not be published in Kidney International Reports® or presented onsite. WCN organizers will not be held responsible for non-publication.
- If the presenting author is unable to attend, a co-author may present the abstract instead, provided they are registered.
- The original presenter must inform the Abstract team ([email protected]) of the change by January 14, 2026 and provide the registration number of the new presenting author at the same time. Failure to do so will result in abstract withdrawal. No exceptions.
- Only abstracts with a placeholder submission by October 22, 2025, will be considered.
- Abstract handling fee is 100 USD per abstract, non-refundable. The fee is not waived for low-income country applicants.
- All copyrights are assigned to the International Society of Nephrology (ISN).
- To submit a late-breaking clinical trials abstracts: log in to your congress profile, go to My Abstracts > Submit New Abstract > Select “Late-breaking Abstract Submission”.
Post-submission updates
- To update your abstract, submit a letter of intent to [email protected] by January 14, 2026.
- The submission portal will temporarily reopen until January 14, 2026, for authors to make final modifications.Abstract submission confirmation and notification of acceptance
Abstract submission confirmation and notification of acceptance
After submitting your abstract, you will receive a confirmation email within two business days. If you do not see the email, please check your spam folder.
For submissions made on the final deadline (October 22, 2025), if you do not receive confirmation within 48 hours, contact [email protected] to ensure your submission was received.
Authors of accepted abstracts will be notified via email by December 3, 2025.
Abstract awards
Discover the awards that will be celebrated at WCN’26 and learn how your work could be recognized on the global stage.
Best Abstract Awards
Awarded to the top three abstracts selected by the Abstract committee
Prize:
- One year of complimentary ISN membership for 2026. If the winner already has a current ISN membership for 2026, alternative options will be offered
- Award certificate
- Recognition on the WCN’26 website, app, and ISN social media channels
Most Viewed e-Poster Award
Awarded to the most viewed e-poster during the congress, March 28-31, 2026
Eligibility: The abstract submitter must be registered for WCN’26 by January 14, 2026
Prize:
- One year of complimentary ISN membership for 2026. If the winner already has a current ISN membership for 2026, alternative options will be offered
- Award certificate
- Recognition on the WCN’26 website, app, and ISN social media channels
ISN Grants Best Abstract Awards
Awarded to the best three abstracts submitted by participants in the ISN Fellowship, Clinical Research and Mentorship programs (three awards per program)
Eligibility:
- Abstract authors must have participated in the ISN Fellowship, Clinical Research or Mentorship program within the past five years
- Submitted abstract must be related to their activities in that program
Prize:
- Complimentary registration for WCN’26
- Monetary prize for each program’s winners (more information to come)
- Presentation of the abstract at the Grants Awards session at WCN’26
- Award certificate
- Recognition on the WCN’26 website, app, and ISN social media channels
Young Nephrologists Best Abstract Awards
Two awards will be given for the Best Basic Science Abstract and Best Clinical Research abstract, selected by the ISN Young Nephrologists Committee
Eligibility: Abstract authors must be under 40 years old
Prize:
- Complimentary registration for WCN’26
- Up to €3,500 for travel and accommodation to attend WCN’26
- Presentation of the abstract at the Young Nephrologists Committee session, part of the WCN’26 scientific program